Equity Research, Broker Reports, and media content on Summit Therapeutics

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Summit Therapeutics
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Summit Therapeutics

Company Profile

  • Personnel
  • Glyn Edwards, CEO

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Summit Therapeutics. We currently have 109 research reports from 3 professional analysts.

  • Open: N/A
  • Range Today: N/A
  • 52 Week: 19.5/32.5p
  • Daily Volume: N/A
  • Daily Liquidity: 0.0%
  • # Shares: 0m
  • Market Cap: £68.9m
  • Latest PE (hist): 2.38
  • Div Yield:
Date Source Announcement
17Feb20 17:30 RNS Summit Therapeutics
11Feb20 10:00 GNW AIM Delisting Reminder
10Feb20 14:15 GNW Director/PDMR Shareholding
06Feb20 12:00 GNW Summit Therapeutics to Receive $1.0 Million Milestone Payment from Eurofarma
04Feb20 12:00 GNW Summit Therapeutics to Present at the 2020 BIO CEO & Investor Conference
27Jan20 07:00 GNW Exercise of Restricted Stock Units
24Jan20 12:00 GNW Summit Announces Management Update
  • Frequency of research reports


  • Research reports on

    Summit Therapeutics

  • Providers covering

    Summit Therapeutics